Showing results (101-110 of 321) with videos related to
Sort By:
Pageof 33
The New England Journal of Medicine|July 1, 2011
Clinical effect of point mutations in myelodysplastic syndromesRafael Bejar, Kristen Stevenson, Omar Abdel-Wahab, et al.Blood|October 5, 2014
Distinct effects of concomitant Jak2V617F expression and Tet2 loss in mice promote disease progression in myeloproliferative neoplasmsEdwin Chen, Rebekka K Schneider, Lawrence J Breyfogle, et al.Genome Research|October 3, 2015
Single-cell RNA-seq reveals changes in cell cycle and differentiation programs upon aging of hematopoietic stem cellsMonika S Kowalczyk, Itay Tirosh, Dirk Heckl, et al.Nature Communications|January 19, 2020
Rapid and deep-scale ubiquitylation profiling for biology and translational researchNamrata D Udeshi, Deepak C Mani, Shankha Satpathy, et al.Science (New York, N.Y.)|February 9, 2013
(R)-2-hydroxyglutarate is sufficient to promote leukemogenesis and its effects are reversibleJulie-Aurore Losman, Ryan E Looper, Peppi Koivunen, et al.Science (New York, N.Y.)|December 17, 2013
Genome-scale CRISPR-Cas9 knockout screening in human cellsOphir Shalem, Neville E Sanjana, Ella Hartenian, et al.Plos One|May 3, 2014
Loss of function of TET2 cooperates with constitutively active KIT in murine and human models of mastocytosisSerena De Vita, Rebekka K Schneider, Michael Garcia, et al.Nature|January 19, 2008
Identification of RPS14 as a 5q- syndrome gene by RNA interference screenBenjamin L Ebert, Jennifer Pretz, Jocelyn Bosco, et al.EMBO Molecular Medicine|March 8, 2017
Deletion of ribosomal protein genes is a common vulnerability in human cancer, especially in concert with TP53 mutationsRam Ajore, David Raiser, Marie McConkey, et al.The Journal of Clinical Investigation|June 28, 2022
Degradation of GSPT1 causes TP53-independent cell death in leukemia while sparing normal hematopoietic stem cellsRob S Sellar, Adam S Sperling, Mikołaj Słabicki, et al.Pageof 33